Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Scientific Reports|February 19, 2021
Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney diseaseRenate M Hoogeveen, Simone L Verweij, Yannick Kaiser, et al.
European Journal of Preventive Cardiology|December 1, 2021
Statin therapy and lipoprotein(a) levels: a systematic review and meta-analysisLotte M de Boer, Anna O J Oorthuys, Albert Wiegman, et al.
European Journal of Preventive Cardiology|July 30, 2025
Plasma reduction of apolipoprotein C-III with olezarsen leads to significant reductions in postprandial triglyceride levels: Results from a randomized trialJordan M Kraaijenhof, Merel C Peletier, Nick S Nurmohamed, et al.
Journal of Clinical Lipidology|December 8, 2023
Lipoprotein(a) levels and carotid intima-media thickness in children: A 20-year follow-up studyLotte M de Boer, Barbara A Hutten, Sotirios Tsimikas, et al.
European Heart Journal Open|April 3, 2026
Reduced postprandial lipid accumulation in circulating monocytes by olezarsen attenuates pro-inflammatory changes in hypertriglyceridemic patientsMerel C Peletier, Jordan M Kraaijenhof, Miranda Versloot, et al.
International Journal of Cardiology|May 11, 2020
Short-term regulation of hematopoiesis by lipoprotein(a) results in the production of pro-inflammatory monocytesJohan G Schnitzler, Kikkie Poels, Lotte C A Stiekema, et al.
Vascular Biology (Bristol, England)|February 26, 2026
Endothelial RhoGEF Trio is involved in angiogenesisJeffrey Kroon, Ilse Timmerman, Ilkka Paatero, et al.
Genes|March 28, 2025
Inherited Dyslipidemic Splenomegaly: A Genetic Macrophage Storage Disorder Caused by Disruptive Apolipoprotein E (APOE) VariantsElise A Ferreira, Machteld M Oud, Saskia N van der Crabben, et al.
Open Heart|September 20, 2024
Interleukin 6 plasma levels are associated with progression of coronary plaquesJordan M Kraaijenhof, Nick S Nurmohamed, Evangelos Tzolos, et al.
Pageof 9